Skip to main content

Clonazepam (International)

In the US, Clonazepam (clonazepam systemic) is a member of the following drug classes: benzodiazepine anticonvulsants, benzodiazepines and is used to treat Anxiety, Benzodiazepine Withdrawal, Bipolar Disorder, Borderline Personality Disorder, Burning Mouth Syndrome, Chronic Myofascial Pain, Cluster-Tic Syndrome, Epilepsy, Hyperekplexia, Insomnia, Migraine Prevention, Night Terrors, Obsessive Compulsive Disorder, Panic Disorder, Periodic Limb Movement Disorder, Primary Orthostatic Tremor, Restless Legs Syndrome, Seizure Prevention, Sleep Paralysis and Temporomandibular Joint Disorder.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiepileptic agent

Benzodiazepine derivative

Chemical Name

2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-

Foreign Names

Generic Names

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.